期刊文献+

抗MDA5抗体在无肌病皮肌炎诊断中的意义

Significance of Anti-MDA5 Antibody in the Diagnosis of No Myopathy Myositis
下载PDF
导出
摘要 目的探讨抗黑色瘤分化相关基因(MDA5)抗体对无肌病皮肌炎(ADM)的诊断意义。方查阅270例资料完整的风湿病患者的住院病历,其中无肌病皮肌炎(ADM)患者30例(ADM组),非ADM患者240例(非ADM组)。检测患者外周血抗MDA5抗体。计算抗MDA5抗体的敏感度和特异度,并对两组患者检测结果进行对比分析。结果抗MDA5抗体在ADM组患者血清中的阳性率33.33%,非ADM组阳性率0.42%。抗MDA5抗体对ADM的敏感性和特异性分别为33.33%和99.58%。结论抗CCP抗体对ADM具有一定的敏感性和高度的特异性,对ADM的诊断具有重要意义。 Objective To investigate the diagnostic value of anti-melanoma differentiation related gene(MDA5) antibody in the absence of myopathy dermatomyositis(ADM). Methods A total of 270 inpatients with complete data on rheumatic diseases were enrolled, including 30 patients with no myopathy dermatomyositis(ADM)(ADM group) and 240 patients with non-ADM(non-ADM group). The patient’s peripheral blood anti-MDA5 antibody was detected. The sensitivity and specificity of anti-MDA5 antibodies were calculated, and the results of the two groups were compared and analyzed.Results The positive rate of anti-MDA5 antibody in serum of ADM group was 33.33%, and the positive rate of non-ADM group was 0.42%. The sensitivity and specificity of anti-MDA5 antibodies to ADM were 33.33% and 99.58%, respectively. Conclusion Anti-CCP antibody has certain sensitivity and high specificity to ADM, which is of great significance for the diagnosis of ADM.
作者 张佳林 陈少英 ZHANG Jia-lin;CHEN Shao-ying(Zhangzhou Hospital, Fujian Medical University, Zhangzhou 363000, China)
出处 《中国医药指南》 2019年第18期21-21,23,共2页 Guide of China Medicine
关键词 无肌病皮肌炎 抗MDA5抗体 诊断 No myopathy dermatomyositis Anti-MDA5 antibody Diagnosis
  • 相关文献

参考文献2

二级参考文献28

  • 1张清安,李中学,向兰兰,黄娟.皮肌炎与多发性肌炎73例临床分析[J].中国实用内科杂志,2005,25(4):354-355. 被引量:4
  • 2Sontheimer RD. Would a new name hasten the acceptance of amyopathie dermatomyositis (dermatomyositis sins myositis) as adistinctive subset within the idiopathic inflammatory dermatomy- opathies spectrum of clinical illness? J Am Acad Dermatol, 2002, 46(4): 626-636.
  • 3Stonecipher MR, Jorizzo JL, White WL, et al. Cutaneous changes of dermatomyositis in patients with normal muscle enzymes: der- matomyositis sine myositis? J Am Acad Dermatol, 1993, 28 (6): 951-956.
  • 4Sontheimer RD. Cutaneous features of classic dermatomyositis and amyopathic dermatomyositis. Curr Opin Rheumatol, 1999, 11 (6): 475 -482.
  • 5Cao H, Parikh TN, Zheng J. Amyopathic dermatomyositis or der- matomyositis-like skin disease: retrospective review of 16 cases with amyopathic dermatomyositis. Clin Rheumatol, 2009, 28(8): 979-984.
  • 6Airio A, Kautiainen H, Hakala M. Prognosis and mortality of polymyositis and dermatomyositis patients. Clin Rheumatol, 2006, 25(2): 234-239.
  • 7Sato S, Hirakata M, Kuwana M, et al. Autoantibodies to a 140-kd polypeptide, CADM-140, in Japanese patients with clinically amyopathic dermatomyositis. Arthritis Rheum, 2005, 52 (5): 1571-1576.
  • 8Sato S, Hoshino K, Satoh T, et al. RNA helicase encoded by melanoma differentiation-associated gene 5 is a major autoantigen in patients with clinically amyopathic dermatomyositis: Associa- tion with rapidly progressive interstitial lung disease. Arthritis Rheum, 2009, 60(7): 2193-2200.
  • 9Nakashima R, Imura Y, Kobayashi S, et al. The RIG-I-like receptor IFIHI/MDA5 is a dermatomyositis-specific autoantigen identified by the anti-CADM-140 antibody. Rheumatology (Oxford), 2010, 49(3): 433-440.
  • 10Bohan A, Peter JB. Polymyositis and dermatomyositis (first of two parts). N Eng1 J Med, 1975, 292(7): 344-347.

共引文献20

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部